rs142245618

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004525.3(LRP2):​c.13685T>C​(p.Val4562Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,611,740 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 15 hom. )

Consequence

LRP2
NM_004525.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.580

Publications

10 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0045801103).
BP6
Variant 2-169132617-A-G is Benign according to our data. Variant chr2-169132617-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211393.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00191 (291/152314) while in subpopulation NFE AF = 0.00335 (228/68032). AF 95% confidence interval is 0.00299. There are 0 homozygotes in GnomAd4. There are 137 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 15 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.13685T>C p.Val4562Ala missense_variant Exon 77 of 79 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.13556T>C p.Val4519Ala missense_variant Exon 76 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.12761T>C p.Val4254Ala missense_variant Exon 77 of 79 XP_047300296.1
LRP2XM_011511184.3 linkc.11396T>C p.Val3799Ala missense_variant Exon 62 of 64 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.13685T>C p.Val4562Ala missense_variant Exon 77 of 79 NM_004525.3 ENSP00000496870.1 P98164

Frequencies

GnomAD3 genomes
AF:
0.00191
AC:
291
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00335
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00189
AC:
475
AN:
251372
AF XY:
0.00187
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000984
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.00324
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00297
AC:
4336
AN:
1459426
Hom.:
15
Cov.:
29
AF XY:
0.00289
AC XY:
2098
AN XY:
726220
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33418
American (AMR)
AF:
0.000962
AC:
43
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.000754
AC:
65
AN:
86214
European-Finnish (FIN)
AF:
0.00170
AC:
91
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00359
AC:
3980
AN:
1109816
Other (OTH)
AF:
0.00237
AC:
143
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
175
351
526
702
877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00191
AC:
291
AN:
152314
Hom.:
0
Cov.:
32
AF XY:
0.00184
AC XY:
137
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000577
AC:
24
AN:
41564
American (AMR)
AF:
0.00137
AC:
21
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00335
AC:
228
AN:
68032
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00297
Hom.:
3
Bravo
AF:
0.00189
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00185
AC:
225
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00300
EpiControl
AF:
0.00255

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
May 23, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 25, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Donnai-Barrow syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRP2: BP4, BS2 -

LRP2-related disorder Benign:1
Dec 06, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
5.8
DANN
Benign
0.86
DEOGEN2
Benign
0.094
T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.49
.;T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.0046
T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
-0.34
N;N
PhyloP100
-0.58
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.3
.;N
REVEL
Benign
0.27
Sift
Benign
0.40
.;T
Sift4G
Benign
0.25
.;T
Polyphen
0.0010
B;B
Vest4
0.055
MVP
0.14
MPC
0.14
ClinPred
0.0023
T
GERP RS
-7.8
Varity_R
0.040
gMVP
0.26
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142245618; hg19: chr2-169989127; API